-
COVID-19 Ag Test At Home OTC (EUA Approved)The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
-
COVID-19 Ag TestCorDx’s COVID-19 Ag Test is used in qualitative detection of COVID-19 antigen in human nasopharyngeal or pharyngeal swab specimens. Instead of waiting for results to return from the lab, clinicians and medical professionals benefit from accurate qualitative results within 10–15 minutes.
-
COVID-19 IgM/IgG Ab TestCorDx’s COVID-19 IgM/IgG Ab Test is used in the qualitative detection of the IgM and IgG antibodies of SARS-CoV-2 (COVID-19) in human serum/plasma or whole blood. Instead of waiting for results to return from the lab, clinicians and medical professionals benefit from accurate qualitative results in just 10–15 minutes.
-
COVID-19 Ag Nasopharyngeal Swab TestCorDx’s COVID-19 Ag Nasopharyngeal Swab Test is a chromatographic immunoassay test for the qualitative detection of the COVID-19 antigen in human nasopharyngeal swab specimens. The COVID-19 Ag Test provides a fast and straightforward method to gain qualitative results for the diagnosis of COVID-19, allowing clinicians and medical staff to contain the spread of the infection quickly and effectively.
The target antigen detected by the COVID-19 Ag Test is N protein. The spike protein is the primary mutation site of the UK mutant strain (B.1.1.7), South African mutant (501.V2), and Brazil mutant (P.1). Therefore, the COVID-19 Ag Nasopharyngeal Swab Test can detect the virus antigens of these three mutants.